Patent intelligence · US
US 11596610
Compositions in support of health and mental accuity
Compositions in support of health and mental accuity
Patent details — US 11596610
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 7, 2023
- Expiration
- Mar 2, 2043
- Applicant
- HIGHER OPTIONS GLOBAL, INC.
- Claims
- 20
- CPC classes
- A61K, A61K31/05, A61K31/197, A61K31/198
Quick answer
US 11596610 (Compositions in support of health and mental accuity) is held by HIGHER OPTIONS GLOBAL, INC.. Status: granted. Granted Mar 7, 2023. Expires Mar 2, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- HIGHER OPTIONS GLOBAL, INC.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K31/05, A61K31/197, A61K31/198, A61K31/352, A61K31/4045
More from HIGHER OPTIONS GLOBAL, INC.
Related pharmaceutical patents in our USPTO index.
-
US 10117937
Highly branched alpha-D-glucans
granted -
US 9289513
Targeted cytokine for treatment of musculoskeletal diseases
granted -
US 8685932
Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases
granted -
US 6770283
DNA expression systems based on alphaviruses
expired -
US 6692750
Alphavirus expression vector
expired -
US 6566093
Alphavirus cDNA vectors
expired -
US 6224879
Alphavirus expression vector
expired
Frequently asked questions
What is US patent 11596610?
US 11596610 (Compositions in support of health and mental accuity) is held by HIGHER OPTIONS GLOBAL, INC.. Status: granted. Granted Mar 7, 2023. Expires Mar 2, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11596610?
HIGHER OPTIONS GLOBAL, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does US 11596610 expire?
Our index shows an expiration date of Mar 2, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.